Cargando…

Increase of CSF inflammatory profile in a case of highly active multiple sclerosis

BACKGROUND: Clinical and imaging follow-up coupled with cerebrospinal fluid (CSF) and possibly serum profiling could provide information on disease activity and disability evolution in multiple sclerosis patients. CASE PRESENTATION: We describe the case of a relapsing-remitting MS patient whose hist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Magliozzi, R., Marastoni, D., Rossi, S., Castellaro, M., Mazziotti, V., Pitteri, M., Gajofatto, A., Monaco, S., Benedetti, M. D., Calabrese, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764139/ https://www.ncbi.nlm.nih.gov/pubmed/31558148 http://dx.doi.org/10.1186/s12883-019-1455-7

Ejemplares similares

Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study
por: Farina, Gabriele, et al.
Publicado: (2017)

Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients
por: Calabrese, Massimiliano, et al.
Publicado: (2015)

CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis
por: Magliozzi, Roberta, et al.
Publicado: (2021)

Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis
por: Magliozzi, Roberta, et al.
Publicado: (2019)

Clinical, MRI, and CSF Markers of Disability Progression in Multiple Sclerosis
por: Gajofatto, Alberto, et al.
Publicado: (2013)

Cerebrospinal Fluid IgM Levels in Association With Inflammatory Pathways in Multiple Sclerosis Patients
por: Magliozzi, Roberta, et al.
Publicado: (2020)

CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis
por: Marastoni, Damiano, et al.
Publicado: (2022)

Intrathecal versus Peripheral Inflammatory Protein Profile in MS Patients at Diagnosis: A Comprehensive Investigation on Serum and CSF
por: Pezzini, Francesco, et al.
Publicado: (2023)

CSF Levels of CXCL12 and Osteopontin as Early Markers of Primary Progressive Multiple Sclerosis
por: Marastoni, Damiano, et al.
Publicado: (2021)

The Prognostic Value of White-Matter Selective Double Inversion Recovery MRI Sequence in Multiple Sclerosis: An Exploratory Study
por: Crescenzo, Francesco, et al.
Publicado: (2021)

Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study
por: Marastoni, Damiano, et al.
Publicado: (2019)

“Ependymal‐in” Gradient of Thalamic Damage in Progressive Multiple Sclerosis
por: Magliozzi, Roberta, et al.
Publicado: (2022)

Microstructural MRI Correlates of Cognitive Impairment in Multiple Sclerosis: The Role of Deep Gray Matter
por: Pitteri, Marco, et al.
Publicado: (2021)

Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis
por: Gajofatto, Alberto, et al.
Publicado: (2015)

Changes in Cerebrospinal Fluid Balance of TNF and TNF Receptors in Naïve Multiple Sclerosis Patients: Early Involvement in Compartmentalised Intrathecal Inflammation
por: Magliozzi, Roberta, et al.
Publicado: (2021)

Are Cerebrospinal Fluid Biomarkers Useful in Predicting the Prognosis of Multiple Sclerosis Patients?
por: Gajofatto, Alberto, et al.
Publicado: (2011)

Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity
por: Gajofatto, Alberto, et al.
Publicado: (2023)

Intrathecal Inflammation in Progressive Multiple Sclerosis
por: Monaco, Salvatore, et al.
Publicado: (2020)

Social Cognition in Multiple Sclerosis: A 3-Year Follow-Up MRI and Behavioral Study
por: Ziccardi, Stefano, et al.
Publicado: (2021)

Unraveling the MRI‐Based Microstructural Signatures Behind Primary Progressive and Relapsing–Remitting Multiple Sclerosis Phenotypes
por: Boscolo Galazzo, Ilaria, et al.
Publicado: (2021)

Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs
por: Mazziotti, Valentina, et al.
Publicado: (2022)

Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy
por: Crescenzo, Francesco, et al.
Publicado: (2020)

Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain
por: Donninelli, Gloria, et al.
Publicado: (2020)

CSF Cytokines in Aging, Multiple Sclerosis, and Dementia
por: Hu, William T., et al.
Publicado: (2019)

CSF profile in primary progressive multiple sclerosis: Re-exploring the basics
por: Abdelhak, Ahmed, et al.
Publicado: (2017)

Spotlight on siponimod and its potential in the treatment of secondary progressive multiple sclerosis: the evidence to date
por: Gajofatto, Alberto
Publicado: (2017)

The Use of the Central Vein Sign in the Diagnosis of Multiple Sclerosis: A Systematic Review and Meta-analysis
por: Castellaro, Marco, et al.
Publicado: (2020)

Coping Strategies and Their Impact on Quality of Life and Physical Disability of People with Multiple Sclerosis
por: Cerea, Silvia, et al.
Publicado: (2021)

Chronic Bedridden Condition Is Reflected by Substantial Changes in Plasma Inflammatory Profile
por: Magliozzi, Roberta, et al.
Publicado: (2022)

Blood and CSF Biomarker Dynamics in Multiple Sclerosis: Implications for Data Interpretation
por: Eikelenboom, M. J., et al.
Publicado: (2011)

Aging, Cellular Senescence, and Progressive Multiple Sclerosis
por: Papadopoulos, Dimitrios, et al.
Publicado: (2020)

Visual-Attentional Load Unveils Slowed Processing Speed in Multiple Sclerosis Patients: A Pilot Study with a Tablet-Based Videogame
por: Pitteri, Marco, et al.
Publicado: (2020)

B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis
por: Reali, Camilla, et al.
Publicado: (2020)

Elevated CSF histamine levels in multiple sclerosis patients
por: Kallweit, Ulf, et al.
Publicado: (2013)

Inflammation-related plasma and CSF biomarkers for multiple sclerosis
por: Huang, Jesse, et al.
Publicado: (2020)

Metabolomic profiling of CSF in multiple sclerosis and neuromyelitis optica spectrum disorder by nuclear magnetic resonance
por: Kim, Hyun-Hwi, et al.
Publicado: (2017)

Brentuximab vedotin: axonal microtubule's Apollyon
por: Mariotto, S, et al.
Publicado: (2015)

Kappa Index versus CSF Oligoclonal Bands in Predicting Multiple Sclerosis and Infectious/Inflammatory CNS Disorders
por: Ferraro, Diana, et al.
Publicado: (2020)

COVID-19 in teriflunomide-treated patients with multiple sclerosis: A case report and literature review
por: Capone, Fioravante, et al.
Publicado: (2021)

CSF/serum matrix metallopeptidase‐9 ratio discriminates neuro Behçet from multiple sclerosis
por: Aldinucci, Alessandra, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3vcrit5a96ask6qvdtgus025fb